癌症患者疼痛和痛苦的社会表现:一种混合方法研究
Edith Salès-Wuillemin1, Catherine Lejeune1, Anthony Clain1
1Laboratoire Psy-DREPI (UR-7458), Université de Bourgogne, Dijon, France.
Qualitative health research
|July 13, 2023
概括
癌症患者认为痛苦是身体的退化,而瘤学家很少提到它. 了解这些关于疼痛和痛苦的不同观点可以改善患者护理和心理健康检测.
科学领域:
- 在瘤学瘤学.
- 心理社会瘤学
- 医学社会学 医学社会学
背景情况:
- 接受癌症治疗的患者经常经历身体疼痛和心理社会困扰,包括痛苦,抑郁和焦虑.
- 社会代表理论为理解健康和疾病经验的共同和不同的感知提供了一个框架.
研究的目的:
- 调查疼痛和痛苦是否是瘤学中的禁忌话题.
- 为了比较癌症患者和他们的瘤学家之间的疼痛和痛苦的社会表现.
主要方法:
- 采用混合方法的方法,利用33次与患者 (n=20) 和瘤学家 (n=13) 的深入采访.
- 量化分析涉及到计算"疼痛"",痛苦"和同义词的自发提及.
- 定性分析侧重于与疼痛和痛苦相关的语义网络.
主要成果:
- 患者将痛苦与身体的退化和脆弱性联系在一起;疼痛意味着疾病的存在.
- 瘤学家的采访显示,没有"痛苦"这个词.
- 瘤学家认为疼痛是疾病进展和治疗耐受性的指标.
结论:
- 患者和瘤学家如何表示疼痛和痛苦存在显著差异.
- 解决这些不同的观点可以增强患者和瘤学家之间的相互理解.
- 改善沟通可能有助于更早地检测癌症患者的抑郁和焦虑.
相关概念视频
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer
48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


